文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

具有抗锥虫和抗利什曼原虫活性的4,8-二取代嘧啶并[5,4-]嘧啶的构效关系研究。

SAR Study of 4,8-Disubstituted Pyrimido[5,4-]pyrimidines Exhibiting Antitrypanosomal and Antileishmanial Activity.

作者信息

Lopes André, Teixeira Sofia, Santarém Nuno, Greco Alessandro, Pagliaro Angela, Keminer Oliver, Gul Sheraz, Cordeiro-da-Silva Anabela, Carvalho Maria Alice

机构信息

Centre of Chemistry of University of Minho (CQUM), Campus de Gualtar, Braga, Portugal and Departamento de Química, Escola de Ciências da Universidade do Minho, Braga 4710-057, Portugal.

Instituto de Investigação e Inovação em Saúde, Universidade do Porto and Institute for Molecular and Cell Biology, University of Porto, Porto 4150-180, Portugal.

出版信息

ACS Med Chem Lett. 2024 Aug 22;15(9):1541-1548. doi: 10.1021/acsmedchemlett.4c00277. eCollection 2024 Sep 12.


DOI:10.1021/acsmedchemlett.4c00277
PMID:39291018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403736/
Abstract

A set of new derivatives of 4,8-disubstituted pyrimido[5,4-]pyrimidines were efficiently synthesized and evaluated against and promastigotes and intramacrophage amastigotes. The cytotoxicity was determined using the THP-1 cell line, and early ADME-Tox was carried out using assays for cytotoxicity (A549 and HEK293 cell lines) and CYP3A4 and hERG cardiotoxicity liabilities. All the new compounds were active against (0.11 μM ≤ IC ≤ 8.72 μM; 1 ≤ selectivity index (SI) ≤ 877), but only eight were active against promastigotes (0.20 μM ≤ IC ≤ 14.88 μM; 1 ≤ SI < 502) with three also active against intramacrophage amastigotes (3.00 μM ≤ IC ≤ 8.51 μM). Compounds , , and were identified as the hit compounds to further develop as antitrypanosomal and antileishmanial agents.

摘要

高效合成了一组4,8-二取代嘧啶并[5,4 -]嘧啶的新衍生物,并对其抗前鞭毛体和巨噬细胞内无鞭毛体的活性进行了评估。使用THP - 1细胞系测定细胞毒性,并使用细胞毒性测定法(A549和HEK293细胞系)以及CYP3A4和hERG心脏毒性评估方法进行早期药物代谢动力学 - 毒性(ADME - Tox)研究。所有新化合物对(0.11 μM≤IC≤8.72 μM;1≤选择性指数(SI)≤877)均有活性,但只有八种对前鞭毛体有活性(0.20 μM≤IC≤14.88 μM;1≤SI < 502),其中三种对巨噬细胞内无鞭毛体也有活性(3.00 μM≤IC≤8.51 μM)。化合物、和被确定为有潜力进一步开发为抗锥虫和抗利什曼原虫药物的活性化合物。

相似文献

[1]
SAR Study of 4,8-Disubstituted Pyrimido[5,4-]pyrimidines Exhibiting Antitrypanosomal and Antileishmanial Activity.

ACS Med Chem Lett. 2024-8-22

[2]
PubChem BioAssays 1063: A Poorly Exploited Source of New Antileishmanial Compounds.

J Parasitol Res. 2025-6-27

[3]
Pyrimido[5,4-]pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents.

ACS Med Chem Lett. 2022-8-9

[4]
Novel pyrazole carboxylate derivatives as lonazolac bioisosteres with selective COX-2 inhibition: design, synthesis and anti-inflammatory activity.

Mol Divers. 2025-5-22

[5]
In Vitro and In Silico Assessments of Curcuminoids and Turmerones from as Novel Inhibitors of Arginase.

Pharmaceuticals (Basel). 2025-6-6

[6]
A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents.

Acta Parasitol. 2021-9

[7]
Antiparasitic Activities of Plants From the Traditional Senegalese Pharmacopoeia: Isolation of Antitrypanosomal and Antileishmanial Ellagic Acid Derivatives From Terminalia Avicennioides.

Chem Biodivers. 2025-6

[8]
Interventions for Old World cutaneous leishmaniasis.

Cochrane Database Syst Rev. 2017-12-1

[9]
Interventions for Old World cutaneous leishmaniasis.

Cochrane Database Syst Rev. 2017-11-17

[10]
Characterizing Leishmania infantum-induced resistance to trivalent stibogluconate (SbIII) through deep proteomics.

J Proteomics. 2024-10-30

引用本文的文献

[1]
Synthesis of Tricyclic and Tetracyclic Lactone Derivatives of Thieno[2,3-]pyrazine or Thieno[2,3-]quinoline: Preliminary Antitumor and Antiparasitic Activity Evaluation.

Molecules. 2025-4-30

本文引用的文献

[1]
Synthetic product-based approach toward potential antileishmanial drug development.

Eur J Med Chem. 2024-1-5

[2]
Pyrimido[5,4-]pyrimidine-Based Compounds as a Novel Class of Antitrypanosomal and Antileishmanial Agents.

ACS Med Chem Lett. 2022-8-9

[3]
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.

Lancet Glob Health. 2021-7

[4]
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.

Clin Microbiol Rev. 2018-8-29

[5]
Leishmaniasis.

Lancet. 2018-8-17

[6]
Human African trypanosomiasis.

Lancet. 2017-6-30

[7]
Control of the leishmaniases.

World Health Organ Tech Rep Ser. 2010

[8]
Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management.

Ther Clin Risk Manag. 2007-10

[9]
Paromomycin in the treatment of leishmaniasis.

Expert Opin Investig Drugs. 2008-5

[10]
Amphotericin biosynthesis in Streptomyces nodosus: deductions from analysis of polyketide synthase and late genes.

Chem Biol. 2001-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索